INM
InMed Pharmaceuticals Inc
NASDAQ: INM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.70
+0.00% today
Updated 2026-04-29
Market cap
$2.43M
P/E ratio
—
P/S ratio
0.54x
EPS (TTM)
$-2.88
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
InMed Pharmaceuticals Inc (INM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-170.10%
Operating margin
-258.60%
ROE
-97.20%
ROA
-49.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.76M | $-1.27M | 48.66% | -42.64% | -46.14% |
| 2007 | $825792.00 | $-1.87M | 61.28% | -138.42% | -226.96% |
| 2008 | $623372.00 | $-922260.00 | 34.94% | -203.75% | -147.95% |
| 2009 | $168422.00 | $-1.06M | 35.35% | -461.34% | -629.28% |
| 2010 | $79463.00 | $-334787.00 | 88.98% | -517.73% | -421.31% |
| 2011 | $39658.00 | $-325466.00 | 31.01% | -977.25% | -820.68% |
| 2012 | — | $-189915.00 | — | — | — |
| 2013 | — | $-46737.00 | — | — | — |
| 2014 | — | $-1.15M | — | — | — |
| 2015 | — | $-3.46M | — | — | — |
| 2016 | — | $-1.84M | — | — | — |
| 2017 | $0.00 | $-3.44M | — | — | — |
| 2018 | $0.00 | $-6.71M | — | — | — |
| 2019 | $0.00 | $-10.01M | — | — | — |
| 2020 | $0.00 | $-8.94M | — | — | — |
| 2021 | $0.00 | $-12.65M | — | — | — |
| 2022 | $1.09M | $-18.60M | 49.89% | -1,265.95% | -1,707.32% |
| 2023 | $4.14M | $-7.95M | 33.93% | -202.60% | -192.18% |
| 2024 | $4.60M | $-7.68M | 23.94% | -176.92% | -166.94% |
| 2025 | $4.94M | $-8.16M | 34.53% | -160.20% | -165.14% |